Explore the words cloud of the EHDEN project. It provides you a very rough idea of what is the project "EHDEN" about.
The following table provides information about the project.
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
|Coordinator Country||Netherlands [NL]|
|Total cost||28˙917˙357 €|
|EC max contribution||14˙105˙750 € (49%)|
1. H2020-EU.3.1.7. (Innovative Medicines Initiative 2 (IMI2))
|Duration (year-month-day)||from 2018-11-01 to 2024-04-30|
Take a look of project's partnership.
|1||ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM||NL (ROTTERDAM)||coordinator||8˙613˙875.00|
|2||SYNAPSE RESEARCH MANAGEMENT PARTNERS SL||ES (MADRID)||participant||944˙375.00|
|3||THE HYVE BV||NL (UTRECHT)||participant||831˙812.00|
|4||ODYSSEUS DATA SERVICES SRO||CZ (PRAHA)||participant||731˙875.00|
|5||THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD||UK (OXFORD)||participant||656˙312.00|
|6||UNIVERSIDADE DE AVEIRO||PT (AVEIRO)||participant||626˙250.00|
|7||NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE||UK (MANCHESTER)||participant||610˙000.00|
|8||INTERNATIONAL CONSORTIUM FOR HEALTHOUTCOMES MEASUREMENT LTD||UK (LONDON)||participant||341˙875.00|
|9||TARTU ULIKOOL||EE (TARTU)||participant||309˙375.00|
|10||FORUM EUROPEEN DES PATIENTS (FPE)||LU (LUXEMBOURG)||participant||236˙250.00|
|11||Stiftelsen WHO Collaborating Centre for International Drug Monitoring||SE (UPPSALA)||participant||203˙750.00|
|12||ABBVIE INC||US (NORTH CHICAGO IL)||participant||0.00|
|13||ASTRAZENECA AB||SE (SODERTAELJE)||participant||0.00|
|14||BAYER AKTIENGESELLSCHAFT||DE (Leverkusen)||participant||0.00|
|15||CELGENE MANAGEMENT SARL||CH (BOUDRY)||participant||0.00|
|16||Eli Lilly and Company Limited||UK (Basingstoke)||participant||0.00|
|17||INSTITUT DE RECHERCHES INTERNATIONALES SERVIER||FR (SURESNES)||participant||0.00|
|18||JANSSEN PHARMACEUTICA NV||BE (BEERSE)||participant||0.00|
|19||NOVARTIS PHARMA AG||CH (BASEL)||participant||0.00|
|20||PFIZER LIMITED||UK (SANDWICH)||participant||0.00|
|21||SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT||FR (Chilly Mazarin)||participant||0.00|
|22||UCB BIOPHARMA SRL||BE (BRUXELLES)||participant||0.00|
Europe is generating huge amounts of patient-level information contained in Electronic Health Record (EHR) systems and other types of health databases. These include structured data in the form of diagnoses, medications, laboratory test results, etc., and unstructured data in clinical narratives. The Electronic Health Data in a European Network (EHDEN) Consortium leverages these vast volumes of data to improve future clinical practice and individual patient outcomes by increasing our understanding of disease and treatment pathways. EHDEN will galvanize transparent and reproducible analytics that will generate valid real-world evidence to improve patient care, and enable medical outcomes-based research at an unprecedented scale. The EHDEN Consortium provides the infrastructure and eco-system supporting disease-specific projects in the IMI Big Data for Better Outcomes (BD4BO) programme. The core of EHDEN is the use of a common data model (OMOP-CDM), standardised outcome assessment (ICHOM), and transparent open-source analytics (OHDSI). The objective of the EHDEN consortium is to provide all the necessary services that enable a distributed European data network to perform fast, scalable and highly reproducible research, while respecting privacy regulations, local data provenance and governance. This will include services and tools to perform data standardization, analytical pipelines, tools to share study results, and tools for stakeholder engagement and training. The EHDEN Consortium combines active participation of stakeholder representatives with proven experience in: a) integrating different data types, methods and technologies to utilize diverse clinical datasets; b) platform development to make methods and datasets Findable, Accessible, Interoperable and Reusable (FAIR); and c) engaging a wide variety of stakeholders, including health technology assessment agencies, regulators and patients.
|Report on SME Certification Procedure and Data Source Grant Awarding Procedure developed and implemented||Documents, reports||2020-04-10 23:45:23|
|Stakeholder mapping||Documents, reports||2020-04-10 23:45:23|
|First version of the Framework for quality benchmarking||Documents, reports||2020-04-10 23:45:23|
|Yearly Progress report on technical framework (1)||Documents, reports||2020-04-10 23:45:23|
|First Report on the implementation of the analytical pipeline for personalized medicine||Documents, reports||2020-04-10 23:45:23|
|Technical framework design and architecture||Documents, reports||2020-04-10 23:45:23|
|ICHOM standards defined using OMOP terminology||Documents, reports||2020-04-10 23:45:23|
|Selected priority therapeutic areas||Documents, reports||2020-04-10 23:45:23|
|Selection of use cases for personalized medicine||Documents, reports||2020-04-10 23:45:23|
|Ethics Advisory Board nomination||Documents, reports||2020-04-10 23:45:23|
|Report on key data source/s of interest for WP1 Use Cases||Documents, reports||2020-04-10 23:45:23|
Take a look to the deliverables list in detail: detailed list of EHDEN deliverables.
|year||authors and title||journal||last update|
The EHDEN consortium
Report on the EHDEN achievements during its foundational year (Nov 2018 - Oct 2019)
published pages: , ISSN: , DOI:
Alina Trifan, JosÃ© LuÃs Oliveira
Patient data discovery platforms as enablers of biomedical and translational research: A systematic review
published pages: 103154, ISSN: 1532-0464, DOI: 10.1016/j.jbi.2019.103154
|Journal of Biomedical Informatics 93||2020-04-10|
Developing Computational Solutions for Personalized Medicine.
published pages: , ISSN: , DOI:
Edward Burn, James Weaver, Daniel Morales, Albert Prats-Uribe, Antonella Delmestri, Victoria Y Strauss, Ying He, Danielle E Robinson, Rafael Pinedo-Villanueva, Spyros Kolovos, Talita Duarte-Salles, William Sproviero, Dahai Yu, Michel Van Speybroeck, Ross Williams, Luis H John, Nigel Hughes, Anthony G Sena, Ruth Costello, Belay Birlie, David Culliford, Caroline O\'Leary, Henry Morgan, Theresa Burkar
Opioid use, postoperative complications, and implant survival after unicompartmental versus total knee replacement: a population-based network study
published pages: e229-e236, ISSN: 2665-9913, DOI: 10.1016/s2665-9913(19)30075-x
|The Lancet Rheumatology 1/4||2020-04-10|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EHDEN" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "EHDEN" are provided by the European Opendata Portal: CORDIS opendata.
Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugsRead More
Bringing a prophylactic Ebola vaccine to licensureRead More
Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitorsRead More